tocophersolan has been researched along with tanshinone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Fang, X; Li, Y; Wang, Y; Zhang, J; Zhou, D | 1 |
| Hu, S; Li, J; Wu, F; Zhang, S; Zhang, X | 1 |
2 other study(ies) available for tocophersolan and tanshinone
| Article | Year |
|---|---|
TPGS-g-PLGA/Pluronic F68 mixed micelles for tanshinone IIA delivery in cancer therapy.
Topics: Abietanes; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Biological Availability; Carcinoma, Hepatocellular; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Hep G2 Cells; Humans; Lactic Acid; Liver Neoplasms; Male; Micelles; Poloxamer; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Wistar; Serum Albumin, Bovine; Vitamin E | 2014 |
Triphenylphosphonium and D-α-tocopheryl polyethylene glycol 1000 succinate-modified, tanshinone IIA-loaded lipid-polymeric nanocarriers for the targeted therapy of myocardial infarction.
Topics: Abietanes; Animals; Cell Death; Cell Survival; Drug Carriers; Drug Liberation; Endocytosis; Lipids; Molecular Targeted Therapy; Myocardial Infarction; Nanoparticles; Onium Compounds; Organophosphorus Compounds; Particle Size; Proton Magnetic Resonance Spectroscopy; Rats, Sprague-Dawley; Static Electricity; Tissue Distribution; Vitamin E | 2018 |